PFE

Pfizer

Pfizer (PFE)

NYSE
32.140.02 (0.06%)Updating Price
Delay +15 min
Stock ratings and Insider transaction returns are measured over a
period with
benchmark.
Learn how to set expert rankings:
Investment time frame (1 Year)
TipRanks measures the stock performance over a one-year time period. For Corporate Insiders, this period is measured starting from the transaction date. You can see how well experts have performed on longer, or shorter, time periods by setting this parameter. Now you can conclude if you are taking advice from the right expert.
Benchmark comparison (No Benchmark)
TipRanks allows you to compare each recommendation, or Corporate Insider transaction to the performance of the S&P 500, or to the sector of the company, to determine if the Expert, or Insider outperforms the market or not.
Reset to default Settings
Details

Analysts Covering PfizerAnalyst Ratings

Showing:

Analyst Consensus

Hold

Based on 4 Analyst Ratings


  • 1 Buy
  • 2 Hold
  • 1 Sell

Based on 4 Wall Street analysts offering recommendations for PFE in the last 3 months (by analysts ranked 0 to 5 stars).

Analyst Price Target on PFE

Average Price Target

$35.33

(9.93% Upside)

Based on 4 analysts offering 12 month price targets for PFE in the last 3 months. The average price target is $35.33 with a high estimate of $38.00 and a low estimate of $33.00.

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent recommendations
Analyst Ratings
Article
Jefferies
3.8 out of 5
Jefferies
3.8 out of 5
Hold
$35.00
$35.00
Reiterated
Citigroup
2.5 out of 5
Citigroup
2.5 out of 5
Sell
-
-
Downgraded
BMO Capital
3.9 out of 5
BMO Capital
3.9 out of 5
Hold
$33.00
$33.00
Reiterated
Credit Suisse
3 out of 5
Credit Suisse
3 out of 5
Buy
$38.00
$38.00
Reiterated
Deutsche Bank
0.5 out of 5
Deutsche Bank
0.5 out of 5
Buy
$40.00
$40.00
Reiterated
Bernstein
3.7 out of 5
Bernstein
3.7 out of 5
Buy
$35.00
$35.00
Assigned
Piper Jaffray
2.4 out of 5
Piper Jaffray
2.4 out of 5
Buy
$53.00
$53.00
Reiterated
Goldman Sachs
4.3 out of 5
Goldman Sachs
4.3 out of 5
Hold
$36.00
$36.00
Assigned
No article available
Barclays
4.3 out of 5
Barclays
4.3 out of 5
Buy
$38.00
$38.00
Upgraded
J.P. Morgan
2.8 out of 5
J.P. Morgan
2.8 out of 5
Buy
$39.00
$39.00
Reiterated
No article available
Merrill Lynch
2.4 out of 5
Merrill Lynch
2.4 out of 5
Buy
$36.00
$36.00
Reiterated
Argus Research
3.5 out of 5
Argus Research
3.5 out of 5
Hold
-
-
Downgraded
Berenberg Bank
3.6 out of 5
Berenberg Bank
3.6 out of 5
Hold
$38.00
$38.00
Assigned
No article available
UBS
0.7 out of 5
UBS
0.7 out of 5
Buy
$38.00
$38.00
Reiterated
Leerink Swann
4.6 out of 5
Leerink Swann
4.6 out of 5
Hold
$37.00
$37.00
Reiterated
Morgan Stanley
0.2 out of 5
Morgan Stanley
0.2 out of 5
Hold
-
-
Reiterated
No article available

See the highest rated stocks in the Healthcare sector

Rate Gauge

Blogger Opinions on Pfizer

Blogger Consensus

Bullish: 94%
Sector
Average
Bullish
PFE Blogger consensus is based on 68 Blogger Opinions, the Blogger consensus is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

  • 36% seekingalpha.com
  • 27% fool.com
  • 14% investorplace.com
  • 23% Others
Article
Distribution

Top Blogger Bearish Opinions

VS

Top Blogger Bullish Opinions

  • Buy Pfizer Inc. (PFE) Stock While Its Dividend Is on Sale
  • 3 Dividend Stocks That Prove Boring Is Beautiful
    fool.com
  • 3 Dividend Stocks That Prove Boring Is Beautiful
    fool.com

Filter Opinions

Blogger Opinions

Ranking

UpgradeUpgrade to see the 5 most recent opinions
Blogger Opinions
Article
Investing.com
2.817984288818318 out of 5
Investing.com
Bullish
Bullish
TheStreet.com
4.194384088250041 out of 5
TheStreet.com
Bullish
Bullish
TheStreet.com
4.938993815811466 out of 5
TheStreet.com
Bullish
Bullish
Motley Fool
4.3957880661875315 out of 5
Motley Fool
Bullish
Bullish
Motley Fool
4.990807287314056 out of 5
Motley Fool
Bullish
Bullish
Motley Fool
0.03092094267090062 out of 5
Motley Fool
Bullish
Bullish
Motley Fool
4.67741935483871 out of 5
Motley Fool
Bullish
Bullish
Seeking Alpha
4.212769513621929 out of 5
Seeking Alpha
Bullish
Bullish
Motley Fool
4.542871469162628 out of 5
Motley Fool
Bullish
Bullish
See the 5 highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sector
BULLISH
BEARISH

Corporate Insider Activity on Pfizer

Trend: Corporate Insiders Sold Shares Worth $6.29M in the Last 3 Months.

PFE Insider Transactions

The data in the graph is based on publicly available reports of insider transactions as reported to the SEC.

Insider Confidence Signal

Premium Bannerlock

Upgrade to see Insider confidence signal

Currently not enough data available to determine Insider Confidence Signal

Please return soon as the page is updated accordingly.

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent transactions
Corporate Insider Transactions
SEC
John D. Young
Group President
1.1 out of 5
Group President
1.1 out of 5
Uninformative Sell
-
-
Read SEC form
Rady Johnson
EVP
2.5 out of 5
EVP
2.5 out of 5
Informative Sell
$153,855
$153,855
Read SEC form
Charles H. Hill
EVP
1.4 out of 5
EVP
1.4 out of 5
Informative Sell
$1,226,520
$1,226,520
Read SEC form
Rady Johnson
EVP
2.5 out of 5
EVP
2.5 out of 5
Uninformative Buy
$149,990
$149,990
Read SEC form
Douglas Lankler
EVP
0.6 out of 5
EVP
0.6 out of 5
Informative Sell
$693,200
$693,200
Read SEC form
Mikael Dolsten
President R&D
2.6 out of 5
President R&D
2.6 out of 5
Informative Sell
$1,068,924
$1,068,924
Read SEC form
Albert Bourla
Group President
Not Ranked
Group PresidentNot RankedUninformative Sell
$200,161
$200,161
Read SEC form
Albert Bourla
Group President
Not Ranked
Group PresidentNot RankedUninformative Buy
-
-
Read SEC form
Frank Damelio
EVP
3.2 out of 5
EVP
3.2 out of 5
Uninformative Sell
$1,298,664
$1,298,664
Read SEC form
Frank Damelio
EVP
3.2 out of 5
EVP
3.2 out of 5
Uninformative Buy
-
-
Read SEC form
Freda Lewis-Hall
EVP
Not Ranked
EVPNot RankedUninformative Sell
$580,566
$580,566
Read SEC form
Freda Lewis-Hall
EVP
Not Ranked
EVPNot RankedUninformative Buy
-
-
Read SEC form
Loretta Cangialosi
Sr. VP, Controller
1.2 out of 5
Sr. VP, Controller
1.2 out of 5
Uninformative Sell
$127,247
$127,247
Read SEC form
Loretta Cangialosi
Sr. VP, Controller
1.2 out of 5
Sr. VP, Controller
1.2 out of 5
Uninformative Buy
-
-
Read SEC form
LUND-JURGENSEN KIRSTEN
Executive Vice President
Not Ranked
Executive Vice PresidentNot RankedUninformative Sell
$69,897
$69,897
Read SEC form
LUND-JURGENSEN KIRSTEN
Executive Vice President
Not Ranked
Executive Vice PresidentNot RankedUninformative Buy
-
-
Read SEC form
Laurie Olson
EVP
1.2 out of 5
EVP
1.2 out of 5
Uninformative Sell
$181,855
$181,855
Read SEC form
Laurie Olson
EVP
1.2 out of 5
EVP
1.2 out of 5
Uninformative Buy
-
-
Read SEC form

News Sentiment on Pfizer

Media Buzz in the last 7 days

0
PFE This
Week
PFE
Weekly Average
50
This Week:
10 articles
Weekly Average:
24.5 articles

News Sentiment in the last 7 days

Premium Bannerlock

Unlock to see News Sentiment
for PFE

PFE This
Week
Sector
Weekly Average
PFE:
100% Bullish
0% Bearish
Sector Average:
66% Bullish
34% Bearish

News Score

Premium Bannerlock

Upgrade to see the News Score
for PFE

Not enough data to generate a news score.

Please return soon as the page is updated accordingly.

Showing:

Media Coverage Analysis

Keywords mentioned in last week’s articles

  • differing interpretations, and
  • covered oncology drugs
  • Pfizer beats 1Q
  • helping to redefine life with cancer
  • living with cancer
  • said Michael Corbo, PhD

See 5 similar stocks with higher news sentiment

Hedge Funds Activity on Pfizer

Trend: Hedge Funds Decreased Holdings by 4.9M Shares Last Quarter.

Hedge Fund Holdings in PFE

Based on 203 Hedge Funds covered by TipRanks.

Hedge Fund Confidence Signal

Premium Bannerlock

Upgrade to see Hedge
Fund Confidence Signal

Very Negative

Based on activity of 35 Hedge Funds in the recent quarter

SoldBought

Filter Activity

Show Actions

Ranking

Hedge Fund Activity
Highbridge Capital Management LLC
1.2068965517241381 out of 5
New
+100.00%
$10.26M
+100.00%
$10.26M0.15%
Soros Fund Mangment LLC
2.167487684729064 out of 5
New
+100.00%
$1.07M
+100.00%
$1.07M0.02%
Columbus Hill Capital Management, L.P.
2.8078817733990147 out of 5
Added
+57.27%
$15.06M
+57.27%
$15.06M0.75%
Ardsley Advisory Partners
0.8128078817733991 out of 5
Added
+41.67%
$581.57K
+41.67%
$581.57K0.09%
Carlson Capital LP
0.5172413793103448 out of 5
Added
+30.18%
$67.79M
+30.18%
$67.79M0.86%
Gotham Asset Management LLC
3.3251231527093594 out of 5
Added
+24.40%
$32.32M
+24.40%
$32.32M0.41%
Clough Capital Partners L P
1.4532019704433496 out of 5
Added
+22.86%
$12.37M
+22.86%
$12.37M0.89%
Paulson & Co Inc
0.41871921182266014 out of 5
Added
+15.70%
$13.94M
+15.70%
$13.94M0.19%
Driehaus Capital Management LLC
0.566502463054187 out of 5
Added
+15.27%
$522.08K
+15.27%
$522.08K0.02%

Similar Stocks to Pfizer

Company
Price
Market Cap
Sector
Analyst Consensus
Analyst Price Target
LLY
Eli Lilly & Co
$77.991.01 (1.31%)
$82.38B
Healthcare
Moderate Buy
$89.44
(14.68% Upside)
MRK
Merck & Company
$64.550.51 (0.80%)
$176.55B
Healthcare
Moderate Buy
$65.67
(1.74% Upside)
NVS
Novartis
$81.060.23 (-0.28%)
$191.76B
Healthcare
Hold
$77.00
(-5.01% Downside)
BMY
Bristol Myers
$54.210.11 (0.20%)
$89.31B
Healthcare
Hold
$55.67
(2.69% Upside)
GSK
GlaxoSmithKline
$42.960.34 (-0.79%)
$104.95B
Healthcare
Hold